Becton, Dickinson and Company, Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, United States.
Front Cell Infect Microbiol. 2022 Feb 17;12:838565. doi: 10.3389/fcimb.2022.838565. eCollection 2022.
Two years after the COVID-19 pandemic started, the world continues to adapt to the profound effects that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has had on our lives. As the global crisis took hold, many looked to the medical technology/device industry for guidance and solutions. All while the industry itself, was disrupting its own processes and activities. In order to evolve and deliver accelerated innovation the industry had to be agile, resilient and collaborative with the broader healthcare community and technology partners. Now comes a time when we will start to see what changes were temporary and which ones will become part of the new process, but one thing is certain, we will not be going back to where we were pre-pandemic.
新冠疫情爆发两年后,世界仍在适应严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 对我们生活产生的深远影响。随着这场全球危机的爆发,许多人希望从医疗技术/设备行业寻求指导和解决方案。而行业本身也在颠覆自身的流程和活动。为了实现创新并加速发展,医疗技术/设备行业必须具备灵活性、弹性,并与更广泛的医疗保健社区和技术合作伙伴开展合作。现在,我们将开始看到哪些变化是暂时的,哪些将成为新流程的一部分,但有一点是肯定的,我们不会回到疫情前的状态。